Business
Business
OpenAI AI Agents Bypassed Security Controls on US Government Websites
OpenAI says its AI agents interacted with US government websites in unintended ways, including bypassing security controls while accessing public data.
Business
India vs US Home Loan Rates: Why the Gap Matters for NRIs
India’s home loan rates start around 7.10% at some PSU banks, while US mortgage rates remain above 7%. Here’s what NRIs and OCIs should consider.
Business
Xi Jinping in US: China, America Agree on $30 Billion Tariff Cuts
China and the US agreed on tariff reductions covering $30 billion of non-sensitive goods in each direction during Xi Jinping’s US visit.
Business
US Appeals Court Upholds Pentagon’s Anthropic Blacklist: What It Means
A US appeals court has upheld the Pentagon’s designation of Anthropic as a national security supply-chain risk. Here’s what the ruling means for Claude and Anthropic.
Business
Tech Mahindra CEO Mohit Joshi’s Turnaround: Margins Near 15% Target
Tech Mahindra CEO Mohit Joshi has steered a major performance turnaround, with Q1 FY27 revenue reaching $1.66 billion and EBIT margins rising to 14.4%.
Business
Repeated ₹2,000 UPI Payments for One Bill Could Trigger Bank Fraud Checks
Splitting a large UPI bill into repeated ₹2,000 payments may avoid the proposed MDR threshold, but unusual payment patterns could trigger bank security checks.
Business
IPO Rush: 10 Issues in Focus as Four IPOs Close on September 25
Ten IPOs were in focus on September 25, with four issues closing, four opening and two continuing their second day of bidding.
Business
Trump-Xi Dinner Brings AI and Tech Giants Into US-China Spotlight
Trump’s White House dinner with Xi Jinping brought leading US tech CEOs together, highlighting AI, chips and technology amid US-China tensions.
Business
India’s Revamped Bilateral Investment Treaty Awaits Cabinet Approval
India’s revamped Bilateral Investment Treaty framework is awaiting Cabinet approval, with local remedies and taxation safeguards expected to remain.
Business
GLP-1 Drugs Face Fresh Scrutiny Over Rare Eye Condition Linked to Vision Loss
GLP-1 drugs face fresh scrutiny over a rare eye condition that can cause vision loss, as studies, regulators and US litigation examine the possible link.